(Press-News.org) Patients with rheumatic conditions are in need of symptom relief and some are turning to herbal cannabis as a treatment option. However, the effectiveness and safety of medical marijuana to treat symptoms of rheumatic conditions such as rheumatoid arthritis, lupus, or fibromyalgia is not supported by medical evidence. A new article published in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), explores the risks associated with using herbal cannabis for medicinal purposes and advises healthcare providers to discourage rheumatology patients from using this drug as therapy.
The reason for the medical interest in herbal cannabis is that the human body has an extensive cannabinoid system comprising molecules and receptors that have effects on many functions including pain modulation. Medical cannabis is commonly used to self-treat severe pain associated with arthritis and musculoskeletal pain. In fact, previous research reports that 80% of marijuana users in a U.S. pain clinic are treating myofascial pain with the drug. In population studies in the U.K. and Australia, up to 33% of individuals report using marijuana to treat arthritis pain. As of June 2013, estimates from the office of Information Commissioner of Canada list "severe arthritis" as the reason the 65% of Canadians who are allowed to possess marijuana for medicinal purposes.
"With the public outcry for herbal cannabis therapy, governments around the world are considering its legalization for medicinal use," explains lead investigator Dr. Mary-Ann Fitzcharles, a researcher and rheumatologist at the McGill University Health Centre (MUHC) and the Research Institute of the MUHC in Quebec, Canada. "Physicians caring for patients who are self-medicating with marijuana need to understand the health implications of using this drug. Our study aims to provide health care professionals with that medical evidence related to medical marijuana use in patients with rheumatic conditions."
In the U.S. twenty states, including the District of Columbia (DC), have legalized cannabis for medical purposes. The present study examines the dosing, administration, efficacy and risks of herbal cannabis in pain management for patients with rheumatic conditions. The health issues with recreational marijuana use in this patient population are not covered.
Concentrations of tetrahydrocannabinol (THC)—the substance found in Cannabis sativa that provides pain relief and alters brain function (psychoactive effect)—vary in the plant material by up to 33% and absorption rates are between 2% and 56%, making the dosing of herbal cannabis unreliable. While cannabis may be ingested, most users prefer to inhale the compound for a quicker response. However, smoking a "joint" is not recommended by the medical community due to adverse effects on the respiratory system from hydrocarbons, tar and carbon monoxide.
Furthermore, there is no formal short-term or long-term study of the effectiveness of herbal cannabis in patients with rheumatic diseases. Studies that show good efficacy of cannabinoids for cancer and neuropathic pain may not be extended to rheumatic diseases because of the differing mechanism in the types of pain.
The study authors highlight that use of medical marijuana comes with inherent risks such as compromised cognitive and psychomotor function. Long-term use of cannabis may lead to mental illness, dependence, addiction and memory issues. In fact, a prior U.S. study of 8,000 adults who used cannabis in the previous year found that the odds of depression were 1.4 times higher in cannabis users compared to non-users.
"At this time, we cannot recommend herbal cannabis for arthritis pain management given the lack of efficacy data, potential harm from the drug, and availability of other therapies for managing pain," concludes Dr. Fitzcharles. "Physicians should discourage rheumatology patients from using medical marijuana as a therapy."
INFORMATION:
This study is published in Arthritis Care & Research. Media wishing to receive a PDF of this article may contact sciencenewsroom@wiley.com.
Full citation: The Dilemma of Medical Marijuana Use by Rheumatology Patients." Mary-Ann Fitzcharles, Daniel J. Clauw, Peter A. Ste-Marie and Yoram Shir. Arthritis Care and Research; Published Online: March 3, 2014 (DOI: 10.1002/acr.22267).
URL Upon Publication: http://doi.wiley.com/10.1002/acr.22267
Author Contact: To arrange an interview with Dr. Fitzcharles, please contact Julie Robert with MUHC at julie.robert@muhc.mcgill.caor 514-934-1934 ext. 71381.
About the Journal
Arthritis Care & Research is an official journal of the American College of Rheumatology (ACR), and the Association of Rheumatology Health Professionals (ARHP), a division of the College. Arthritis Care & Research is a peer-reviewed journal that publishes both original research and review articles that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with arthritis and related disorders, major topics are evidence-based practice studies, clinical problems, practice guidelines, health care economics, health care policy, educational, social, and public health issues, and future trends in rheumatology practice. The journal is published by Wiley on behalf of the ACR. For more information, please visit the journal home page at http://wileyonlinelibrary.com/journal/acr.
About Wiley
Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.
Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's website can be accessed at http://www.wiley.com.
Herbal cannabis not recommended for rheumatology patients
2014-03-03
ELSE PRESS RELEASES FROM THIS DATE:
Food allergy nearly doubles among black children
2014-03-03
VIDEO:
Food allergies in children can be frightening. And this might be one of the reasons why several parents choose to not introduce allergenic foods, such as peanuts and dairy, to...
Click here for more information.
ARLINGTON HEIGHTS, Ill. (March 3, 2014) – Children's food allergies are gradually increasing, but they may be as much as doubling among black children. According to a study published today in the March issue of Annals of Allergy, Asthma and Immunology, the scientific ...
Ancient Chinese medicine put through its paces for pancreatic cancer
2014-03-03
SAN ANTONIO (March 3, 2014) – The bark of the Amur cork tree (Phellodendron amurense) has traveled a centuries-long road with the healing arts. Now it is being put through its paces by science in the fight against pancreatic cancer, with the potential to make inroads against several more.
UT Health Science Center researcher A. Pratap Kumar was already exploring the cork tree extract's promise in treating prostate cancer when his team found that deadly pancreatic cancers share some similar development pathways with prostate tumors.
In a paper published today in the journal ...
IU study: College athletes often sidelined from healthy lifestyle later in life
2014-03-03
BLOOMINGTON, Ind. -- An Indiana University study found that elite college athletes -- typically the picture of health and vitality -- often struggle to stay active in later years, facing limitations to their day-to-day activities in middle age that could be a result of injuries during their athletic career.
Lead investigator Janet Simon, a doctoral candidate in the IU School of Public Health-Bloomington's Department of Kinesiology, said researchers have long known that compared to non-athletes, college athletes experience more severe injuries -- and long-term effects ...
Yosemite bears and human food: Study reveals changing diets over past century
2014-03-03
Black bears in Yosemite National Park and elsewhere are notorious for seeking out human food, even breaking into cars and cabins for it. A new study reveals just how much human food has contributed to the diets of Yosemite bears over the past century.
Researchers at the University of California, Santa Cruz, were able to estimate the proportion of human-derived food in bears' diets by analyzing chemical isotopes in hair and bone samples. The results, published in the March issue of Frontiers in Ecology and the Environment, show how bears' diets have changed over the years ...
Entomologists update definitions to tackle resistance to biotech crops and pesticides
2014-03-03
Resistance to pesticides has now been recorded in nearly a thousand pest species, including more than 500 insects, 218 weeds, and 190 fungi that attack plants. The recorded cases of resistance in insects, mites and other arthropods, which include resistance to multiple pesticides per species, more than doubled from 5,141 in 1990 to 11,254 in 2013. A first step in tackling this growing global problem is establishing a common vocabulary, because the current jumble of terms fosters confusion among scientists in academia, industry and government. To address this issue, five ...
Plants convert energy at lightning speed
2014-03-03
A new way of measuring how much light a plant can tolerate could be useful in growing crops resilient to a changing climate, according to scientists from Queen Mary University of London.
"This is the first time we have been able to quantify a plant's ability to protect itself against high light intensity," said Professor Alexander Ruban, co-author of the study and Head of the Cell and Molecular Biology Division at Queen Mary's School of Biological and Chemical Science.
Professor Ruban added: "A changing climate will lead to fluctuations in temperature, humidity, drought ...
Mandatory arrest in domestic violence call-outs causes early death in victims
2014-03-03
New research from a major 'randomised' arrest experiment 23 years ago finds that domestic violence victims whose partners were arrested on misdemeanor charges – mostly without causing injury – were 64% more likely to have died early, compared to victims whose partners were warned but not removed by police.
Among African-American victims, arrest increased early mortality by a staggering 98% – as opposed to white victims, whose mortality was increased from arrest by just 9%. The research also found that employed victims suffered the worst effects of their partners' arrests. ...
As one food allergy resolves, another may develop
2014-03-02
Some children who outgrow one type of food allergy may then develop another type of allergy, more severe and more persistent, to the same food. A new study by pediatric allergy experts suggests that health care providers and caregivers carefully monitor children with food allergies to recognize early signs of eosinophilic esophagitis (EoE), a severe and often painful type of allergy that has been increasing in recent years.
"These two types of allergy have some elements in common, but patients with EoE usually don't go on to develop tolerance to the foods that trigger ...
In first moments of infection, a division and a decision
2014-03-02
Using technologies and computational modeling that trace the destiny of single cells, researchers at the University of California, San Diego School of Medicine describe for the first time the earliest stages of fate determination among white blood cells called T lymphocytes, providing new insights that may help drug developers create more effective, longer-lasting vaccines against microbial pathogens or cancer.
The findings are published in the March 2, 2014 online issue of Nature Immunology.
Naïve T lymphocytes patrol the front lines of the human body’s defense against ...
European flood risk could double by 2050
2014-03-02
Losses from extreme floods in Europe could more than double by 2050, because of climate change and socioeconomic development. Understanding the risk posed by large-scale floods is of growing importance and will be key for managing climate adaptation.
Current flood losses in Europe are likely to double by 2050, according to a new study published in the journal Nature Climate Change by researchers from the International Institute for Applied Systems Analysis (IIASA), the Institute for Environmental Studies in Amsterdam, and other European research centers. Socioeconomic ...